232 related articles for article (PubMed ID: 34637322)
1. Brain-Protective Mechanisms of Transcription Factor NRF2: Toward a Common Strategy for Neurodegenerative Diseases.
Cuadrado A
Annu Rev Pharmacol Toxicol; 2022 Jan; 62():255-277. PubMed ID: 34637322
[TBL] [Abstract][Full Text] [Related]
2. Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development.
Robledinos-Antón N; Fernández-Ginés R; Manda G; Cuadrado A
Oxid Med Cell Longev; 2019; 2019():9372182. PubMed ID: 31396308
[TBL] [Abstract][Full Text] [Related]
3. Redox regulation by NRF2 in aging and disease.
Schmidlin CJ; Dodson MB; Madhavan L; Zhang DD
Free Radic Biol Med; 2019 Apr; 134():702-707. PubMed ID: 30654017
[TBL] [Abstract][Full Text] [Related]
4. The role of Nrf2 signaling in counteracting neurodegenerative diseases.
Dinkova-Kostova AT; Kostov RV; Kazantsev AG
FEBS J; 2018 Oct; 285(19):3576-3590. PubMed ID: 29323772
[TBL] [Abstract][Full Text] [Related]
5. Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases.
Buendia I; Michalska P; Navarro E; Gameiro I; Egea J; León R
Pharmacol Ther; 2016 Jan; 157():84-104. PubMed ID: 26617217
[TBL] [Abstract][Full Text] [Related]
6. NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches.
Sivandzade F; Prasad S; Bhalerao A; Cucullo L
Redox Biol; 2019 Feb; 21():101059. PubMed ID: 30576920
[TBL] [Abstract][Full Text] [Related]
7. Modulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseases.
Pajares M; Cuadrado A; Rojo AI
Redox Biol; 2017 Apr; 11():543-553. PubMed ID: 28104575
[TBL] [Abstract][Full Text] [Related]
8. Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.
Johnson DA; Johnson JA
Free Radic Biol Med; 2015 Nov; 88(Pt B):253-267. PubMed ID: 26281945
[TBL] [Abstract][Full Text] [Related]
9. Reasonably activating Nrf2: A long-term, effective and controllable strategy for neurodegenerative diseases.
Li Q; Xing S; Chen Y; Liao Q; Li Q; Liu Y; He S; Feng F; Chen Y; Zhang J; Liu W; Guo Q; Sun Y; Sun H
Eur J Med Chem; 2020 Jan; 185():111862. PubMed ID: 31735576
[TBL] [Abstract][Full Text] [Related]
10. [Role of Nrf2 in neurodegenerative diseases and recent progress of its activators].
Zhao CY; Wang XL; Peng Y
Yao Xue Xue Bao; 2015 Apr; 50(4):375-84. PubMed ID: 26223117
[TBL] [Abstract][Full Text] [Related]
11. Recent progress in the development of small molecule Nrf2 activators: a patent review (2017-present).
Zhou H; Wang Y; You Q; Jiang Z
Expert Opin Ther Pat; 2020 Mar; 30(3):209-225. PubMed ID: 31922884
[No Abstract] [Full Text] [Related]
12. Activation of Nrf2 signaling as a common treatment of neurodegenerative diseases.
Dinkova-Kostova AT; Kazantsev AG
Neurodegener Dis Manag; 2017 Apr; 7(2):97-100. PubMed ID: 28534719
[No Abstract] [Full Text] [Related]
13. Role of Nrf2 in aging, Alzheimer's and other neurodegenerative diseases.
George M; Tharakan M; Culberson J; Reddy AP; Reddy PH
Ageing Res Rev; 2022 Dec; 82():101756. PubMed ID: 36243357
[TBL] [Abstract][Full Text] [Related]
14. Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function.
Esteras N; Dinkova-Kostova AT; Abramov AY
Biol Chem; 2016 May; 397(5):383-400. PubMed ID: 26812787
[TBL] [Abstract][Full Text] [Related]
15. Activating or Inhibiting Nrf2?
Chu XY; Liu YM; Zhang HY
Trends Pharmacol Sci; 2017 Nov; 38(11):953-955. PubMed ID: 28886953
[TBL] [Abstract][Full Text] [Related]
16. NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases.
Cores Á; Piquero M; Villacampa M; León R; Menéndez JC
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32545924
[TBL] [Abstract][Full Text] [Related]
17. Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases.
Lim JL; Wilhelmus MM; de Vries HE; Drukarch B; Hoozemans JJ; van Horssen J
Arch Toxicol; 2014 Oct; 88(10):1773-86. PubMed ID: 25164826
[TBL] [Abstract][Full Text] [Related]
18. Role of the Keap1/Nrf2 pathway in neurodegenerative diseases.
Yamazaki H; Tanji K; Wakabayashi K; Matsuura S; Itoh K
Pathol Int; 2015 May; 65(5):210-9. PubMed ID: 25707882
[TBL] [Abstract][Full Text] [Related]
19. Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease.
Sharma V; Kaur A; Singh TG
Biomed Pharmacother; 2020 Sep; 129():110373. PubMed ID: 32603894
[TBL] [Abstract][Full Text] [Related]
20. Ozone: a natural bioactive molecule with antioxidant property as potential new strategy in aging and in neurodegenerative disorders.
Scassellati C; Galoforo AC; Bonvicini C; Esposito C; Ricevuti G
Ageing Res Rev; 2020 Nov; 63():101138. PubMed ID: 32810649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
